Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-03-13-Speech-3-266"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20020313.11.3-266"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:translated text |
".
Mr President, the honourable Member’s question relates to two realities: the Action Plan and the World Fund.
The Council would urge the honourable Member to approach the Commission directly, since it is represented on the management board of the World Fund, in order to obtain more precise information on the Fund’s activities.
Firstly, in relation to the Action Plan, the Council would remind the honourable Member that in the Resolution which it adopted on 14 May 2001 on the programme for action and the speeding up of the fight against HIV (AIDS), malaria and tuberculosis in the context of a reduction in poverty (document 8495/01), the Council explained the actions it considers essential in the fight against these three diseases.
The actions include, firstly, access to pharmaceutical products and, in particular, the flexible application of the ADPIC (Trips) agreement in relation to intellectual property, which allows us to confront public health problems, amongst other things, through the discretionary power to grant obligatory licences in certain exceptional circumstances, including those involving the protection of public health.
Secondly, it is a question of strengthening and increasing the financial contributions in the field of research and development. It is particularly important both to increase the capacity of the developing countries and to offer incentives for the development of specific universal public services, such as new treatments and vaccines.
Another action is the participation in world associations. The objective consists of strengthening the cooperation agreements amongst the Member States with the WHO, the UNO (AIDS), the World Bank and other international actors in both the private and the public sectors, for example, the Global Alliance for Vaccines and Immunisation (GAVI).
The Council wishes to stress that that Resolution was presented at the 26th Special Sitting of the General Assembly of the United Nations which took place in New York on 25 to 27 June 2001, during which the European Union actively participated in the drawing up of the final declaration.
Secondly, with regard to the World Fund for Fighting AIDS, Tuberculosis and Malaria, the Council would remind the honourable Member of the European Parliament and Council Decision adopted on 6 December 2001, on the European Community contribution to the World Fund for Fighting HIV (AIDS), Tuberculosis and Malaria. In accordance with that decision, the Commission will contribute EUR 600 million to that world fund for 2001, which will be paid within the framework of a funding agreement to be reached between the Commission and the World Bank. That Decision also stipulates that in 2002 the Commission must present the European Parliament and the Council with a first report on the management and working methods of the World Fund.
With regard to future contributions, the Council is waiting for the Commission to present it with proposals for modifications to the existing Regulations. In particular, the Regulation of 24 March 1997 on actions in the field of HIV (AIDS) in the developing countries, which also includes interventions in the field of genetic health, what is know as ‘reproductive health’, as well as that of 22 July 1997 on aid for demographic policies and programmes in the developing countries.
With regard to the activities so far carried out by the Fund, the Council wishes to tell the honourable Member that on 29 January 2002 the management board meeting in Geneva approved its first presentation of proposals for funding of associations in countries seriously affected by epidemics. The initial series of subsidies, which will be awarded in April, will be the first granted by the Fund. The second meeting of the Fund’s board must take place in New York at the end of April."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples